Astrocyte lineage differentiation

Astrocyte lineage differentiation refers to the process by which neural progenitor or glial progenitor cells develop into astrocytes, the most abundant glial cell type in the CNS[1][7][8]. This process is regulated by complex molecular signaling pathways, including those involving bone morphogenetic proteins (BMPs), leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), Notch, and others[4][6][7]. Astrocyte differentiation is essential for normal formation and maintenance of brain architecture, synaptic maturation, neuronal activity regulation, and response to injury. Disruptions in this process can have implications for neurodevelopmental and neurodegenerative diseases[5][8]. Although the process can be influenced in cell culture or regenerative therapy contexts by cytokines and transcription factors, it is not itself a direct drug target or receptor. This entry does not correspond to a druggable target, molecule, receptor, or protein, but rather to a key developmental process in neurobiology.

Other names

Astrocyte differentiationAstrocyte lineage commitmentAstrogenesis

Not applicable (no drugs "target" the process directly, but some cytokines and growth factors can promote or induce astrocyte differentiation)